AMLX

Q: What is the price of Amylyx Pharmaceuticals Inc (AMLX) today?

A cotação de Amylyx Pharmaceuticals Inc (AMLX) hoje está em $ 15.20, com uma variação de The stock began the year trading around $ 12.08 and is currently priced at $ 15.20. negociando na casa dos $ 12.08 e hoje está em $ 15.20. Acompanhe o and track broader market trends directly on the platform.

Q: When does Amylyx Pharmaceuticals Inc (AMLX) pay dividends?

Amylyx Pharmaceuticals Inc (AMLX) did not pay dividends over the past year.

Q: Is Amylyx Pharmaceuticals Inc (AMLX) a good investment?

Atualmente, Amylyx Pharmaceuticals Inc (AMLX) está cotada a $ 15.20, com um P/L de -10.46, This represents a -851% premium compared to its historical average P/E. uma variação de 212.11 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 212.11%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Amylyx Pharmaceuticals Inc

Price

$ 15.20

return (12m)

212.11%

p/e

-10.46

p/bv

4.96

DIVIDEND YIELD

0.00%

AMLX price

AMLX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment AMLX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-6.58%

3 months

8.73%

1 year

212.11%

2 years

687.56%

5 years

0.00%

10 years

0.00%

Fundamentals AMLX

review the fundamentals of Amylyx Pharmaceuticals Inc shares

P/E

-10.46

Sector: 7.95 Industry: 7.95

P/S (PSR)

Sector: 2.42 Industry: 2.42

P/BV

4.96

Sector: 2.12 Industry: 2.12

DIVIDEND YIELD (DY)

0.00%

Sector: 0.67% Industry: 0.67%

ROA

-43.51%

Sector: 0.35% Industry: 0.35%

ROE

-47.41%

Sector: 4.26% Industry: 4.26%

ROIC

Sector: -75.62% Industry: -75.62%

NET MARGIN

0.00%

Sector: 3.02% Industry: 3.02%

GROSS MARGIN

0.00%

Sector: 32.27% Industry: 32.27%

OPERATING MARGIN

0.00%

Sector: 4.86% Industry: 4.86%

EV/EBITDA

-20.88

Sector: 3.59 Industry: 3.59

EV/EBIT

-20.73

Sector: 1.67 Industry: 1.67

PRICE-TO-ASSETS

4.55

Sector: 1.03 Industry: 1.03

BVPS

3.23

Sector: 9.72 Industry: 9.72

EPS

-1.53

Sector: 0.70 Industry: 0.70

EQUITY-TO-ASSETS RATIO

0.92

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.08

Sector: 0.52 Industry: 0.52

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

10.48%

Sector: - Industry: -

Fundamentals AMLX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
META	21.85	6.33	28.97%	0.35%	$ 1.54 T	32.84%
INTR	13.94	1.74	12.49%	1.50%	$ 3.32 B	15.62%
PBR	7.02	1.85	26.37%	5.45%	$ 141.12 B	22.13%
VALE	24.23	1.84	7.59%	6.26%	$ 69.07 B	7.21%
PLTR	211.62	45.93	21.70%	0.00%	$ 343.90 B	36.31%
SHEL	14.58	1.48	10.17%	3.25%	$ 260.09 B	6.68%
BDORY	10.30	0.72	6.98%	2.57%	$ 25.52 B	9.30%
MAIN	10.25	1.69	16.48%	7.06%	$ 5.06 B	83.37%
ENB	22.23	2.53	11.38%	4.97%	$ 119.53 B	11.49%
NSRGY	11.15	6.29	56.41%	3.35%	$ 260.95 B	10.91%
PBR-A	6.32	1.67	26.37%	5.47%	$ 126.95 B	22.13%
ITUB	12.41	2.56	20.61%	2.84%	$ 100.83 B	27.17%
UNH	27.71	3.29	11.85%	2.40%	$ 334.11 B	2.69%
BBSEY	8.26	7.09	85.85%	11.55%	$ 13.49 B	100.00%
SAN	9.74	1.41	14.44%	1.75%	$ 182.90 B	27.40%
TTE	13.33	1.61	12.05%	6.06%	$ 201.15 B	8.20%
RACE	33.04	0.00	0.00%	0.92%	$ 60.40 B	22.35%
TD	11.50	1.98	17.19%	2.87%	$ 180.28 B	34.54%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

AMLX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals Inc

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Amylyx Pharmaceuticals Inc (United States) is listed on the Nasdaq and has a market capitalization of $1.51 Billion, with shareholders equity totaling $305.26 Millions.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Amylyx Pharmaceuticals Inc reported $- in revenue, generating net income of $-144.74 Millions.

Key financial metrics include a P/E ratio of -10.46, a price-to-book (P/B) ratio of 4.96, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AMLX.

Market cap

$ 1.51 Billion

Net worth

$ 305.26 Millions

$ 305,259,000.00

Assets

$ 332.65 Millions

$ 332,645,000.00

Total Shares Outstanding

94.57 Millions

94,565,000

Average Daily Trading Volume

$ 1.50 Million

$ 1,496,291.00

Sector

Others

Industry

Others

AMLX

AMLX revenue and profits

Financial Results AMLX

DRAG THE FRAME TO SEE MORE DATA

AMLX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

SHG - Shinhan Financial Group Co Ltd

$ 67.77 93,32% (12M)

P/E

0.01

2.30%

ROE

7.11%

P/BV

0.00

CRERF - Carrefour SA

$ 20.10 51,42% (12M)

P/E

1.97

6.15%

ROE

10.34%

P/BV

0.20

UNH - UnitedHealth Group Incorporated

$ 369.74 --1,40% (12M)

P/E

27.71

2.40%

ROE

11.85%

P/BV

3.29

STLA - Stellantis NV

$ 7.48 --24,29% (12M)

P/E

-1.02

10.02%

ROE

-32.04%

P/BV

0.33

COR - Cencora Inc.

$ 255.66 --9,26% (12M)

P/E

36.29

0.76%

ROE

77.54%

P/BV

28.14

BLSH - Bullish

$ 41.20 --40,97% (12M)

P/E

-7.76

0.00%

ROE

-23.69%

P/BV

1.84

SHEL - Shell PLC ADR

$ 84.24 34,64% (12M)

P/E

14.58

3.25%

ROE

10.17%

P/BV

1.48

SSNLF - Samsung Electronics Co Ltd

$ 65.21 56,61% (12M)

P/E

19.25

1.58%

ROE

10.38%

P/BV

2.00